EMA – ICH opens public consultation for international harmonization of real-world evidence terminology

The European Medicines Agency has published for public consultation an ICH Reflection Paper on “Pr

Ler mais

ANVISA – List of Active Substances for Periodic Benefit-Risk Evaluation Reports (updated on December 20th, 2021)

On December 13th, 2021, ANVISA published the list of Periodic Benefit-Risk Assessment Reports (RPBR)

Ler mais

ANVISA – Deadline extension for the implementation of packaging process online control and 100% integrity test

After some deliberations between the regulated sector and the regulatory authority, on December 1st,

Ler mais

ANVISA – Guideline on Remote Inspections

On November 25th, 2021, Anvisa published Guideline No. 54/2021 (version 1) on Remote Inspections. Du

Ler mais

EDQM – Notification to CEP holders: Implementation of the European Pharmacopoeia Supplement 10.7

In October 2021, the EDQM (European Directorate for the Quality of Medicines and Healthcare) publish

Ler mais

ANVISA – Publication of new regulation to expand clinical trials with medicinal products in Brazil

On November 3rd, 2021, ANVISA published the Resolution of the Collegiate Board of Directors –

Ler mais

ANVISA – The addition to the application of origin should be submitted by electronic system – Sistema Solicita

In order to improve the link between applications for addition to their respective applications of o

Ler mais

ICH – Review Procedures of ICH M7(R2) and ICH E8(R1) Guidelines Drafts Advance – updated 27th October, 2021

On October 6, 2021, the ICH published updates on the status of the issuance of the second revision o

Ler mais

EMA – Concern on the safety of titanium dioxide could result in reformulation of drug products in Europe (updated on August 10, 2022)

Since 2020, titanium dioxide (TiO2) has been the subject of concern about its safety for use as a fo

Ler mais

ANVISA – Process Optimization for importing Cannabis-based products by individuals in Brazil – updated on November 29th

In October 2021, some important rules were published for the process of importing Cannabis-based pro

Ler mais

EMA – Update of Pre-authorisation guidance for users of the centralised procedure

In July and September, the authority EMA (European Medicines Agency) updated the document Questions

Ler mais

EMA – Update of Pre-authorisation guidance for users of the centralised procedure

In July and September, the authority EMA (European Medicines Agency) updated the document Questions

Ler mais